Kang Y - Search Results

1

Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).

Schechter NM, Choi EJ, Wang ZM, Hanakawa Y, Stanley JR, Kang Y, Clayman GL, Jayakumar A. Schechter NM, et al. Among authors: kang y. Biol Chem. 2005 Nov;386(11):1173-84. doi: 10.1515/BC.2005.134. Biol Chem. 2005. PMID: 16307483

2

Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.

Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL. Mitsudo K, et al. Among authors: kang y. Biochemistry. 2003 Apr 8;42(13):3874-81. doi: 10.1021/bi027029v. Biochemistry. 2003. PMID: 12667078

3

Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.

Jayakumar A, Kang Y, Mitsudo K, Henderson Y, Frederick MJ, Wang M, El-Naggar AK, Marx UC, Briggs K, Clayman GL. Jayakumar A, et al. Among authors: kang y. Protein Expr Purif. 2004 May;35(1):93-101. doi: 10.1016/j.pep.2003.12.004. Protein Expr Purif. 2004. PMID: 15039071

4

Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution.

Jayakumar A, Kang Y, Henderson Y, Mitsudo K, Liu X, Briggs K, Wang M, Frederick MJ, El-Naggar AK, Bebök Z, Clayman GL. Jayakumar A, et al. Among authors: kang y. Arch Biochem Biophys. 2005 Mar 1;435(1):89-102. doi: 10.1016/j.abb.2004.12.012. Arch Biochem Biophys. 2005. PMID: 15680911

5

Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis.

Jayakumar A, Kang Y, Frederick MJ, Pak SC, Henderson Y, Holton PR, Mitsudo K, Silverman GA, EL-Naggar AK, Brömme D, Clayman GL. Jayakumar A, et al. Among authors: kang y. Arch Biochem Biophys. 2003 Jan 15;409(2):367-74. doi: 10.1016/s0003-9861(02)00635-5. Arch Biochem Biophys. 2003. PMID: 12504904

6

Production of serpins using baculovirus expression systems.

Jayakumar A, Cataltepe S, Kang Y, Frederick MJ, Mitsudo K, Henderson Y, Crawford SE, Silverman GA, Clayman GL. Jayakumar A, et al. Among authors: kang y. Methods. 2004 Feb;32(2):177-84. doi: 10.1016/s1046-2023(03)00209-3. Methods. 2004. PMID: 14698630

7

Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.

Henderson YC, Ahn SH, Kang Y, Clayman GL. Henderson YC, et al. Among authors: kang y. Clin Cancer Res. 2008 Aug 1;14(15):4908-4914. doi: 10.1158/1078-0432.CCR-07-1772. Clin Cancer Res. 2008. PMID: 18676765 Free PMC article.

8

An orthotopic model of papillary thyroid carcinoma in athymic nude mice.

Ahn SH, Henderson Y, Kang Y, Chattopadhyay C, Holton P, Wang M, Briggs K, Clayman GL. Ahn SH, et al. Among authors: kang y. Arch Otolaryngol Head Neck Surg. 2008 Feb;134(2):190-7. doi: 10.1001/archoto.2007.36. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18283163

9

The efficacy and safety of molidustat for anemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis.

Kang Y, Zhou M, Jin Q, Geng YL, Wang Y, Lv J. Kang Y, et al. Heliyon. 2024 May 4;10(9):e30621. doi: 10.1016/j.heliyon.2024.e30621. eCollection 2024 May 15. Heliyon. 2024. PMID: 38765138 Free PMC article.

10

Customized m-RCNN and hybrid deep classifier for liver cancer segmentation and classification.

Khan R, Su L, Zaman A, Hassan H, Kang Y, Huang B. Khan R, et al. Among authors: kang y. Heliyon. 2024 May 6;10(10):e30528. doi: 10.1016/j.heliyon.2024.e30528. eCollection 2024 May 30. Heliyon. 2024. PMID: 38765046 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,975 results

Search Page